title: Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3 beta-FAK feedback loop in HTR8SVneo cells.
abstract: Kisspeptin inhibits cancer cell metastasis and placental trophoblast cell migration. Kisspeptin gene expression in the placenta and circulating kisspeptin levels change during normal pregnancy and they are altered in preeclampsia. We therefore assessed the effect of kisspeptin-10 on the in vitro migration of a human placental cell line derived from first trimester extravillious trophoblasts (HTR8SVneo). HTR8SVneo cells specifically bound 125I-Kisspeptin-10 but kisspeptin-10 did not induce inositol phosphate production. Cell migration was inhibited by kisspeptin-10 with a maximal inhibition at 100nM. The signaling pathways involved in inhibition of cell migration were examined. Treatment with kisspeptin-10 elicited phosphorylation of GSK3 beta at Ser9 (which inhibits activity), with a 3-fold increase at 5 min. Transient phosphorylation of ERK1/2 and p38MAPK peaked at 10min. Phosphorylation of focal adhesion kinase (FAK) at Tyr925 increased 3-fold at 10 min. Inhibition of GSK3 beta correlated with release of beta-catenin into the cytoplasm. These signaling events were differentially blocked by inhibitors of G(q/11), Src, EGFR, PI(3)K, PKC and MEK. The data suggest that kisspeptin/GPR54 EGF-receptor transactivation leads to phosphorylation of ERK1/2, causing activation of p90rsk which in turn inhibits GSK3 beta via Ser9 phosphorylation. Inactivation of GSK3 beta results in release of beta-catenin into the cytoplasm, affecting cell-cell adhesion and Tyr925 phosphorylation of FAK, which increases phosphorylation of ERK1/2 via RAS/Raf-1 creating a feedback loop to enhance the effects on migration. These findings indicate that kisspeptin-10 inhibits the migration of human placental trophoblast-derived HTR8SVneo cells by stimulating complex ERK1/2-p90rsk-GSK3 beta-FAK feedback interactions.
authors.affiliation: Centre for Integrated Physiology, University of Edinburgh, School of Biological Sciences, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK. toni@roseweir.co.uk
authors.forename: A K
authors.initials: AK
authors.lastname: Roseweir
authors.forename: A A
authors.initials: AA
authors.lastname: Katz
authors.forename: R P
authors.initials: RP
authors.lastname: Millar
mesh_terms: D002460:Cell Line; D054443:Cell Migration Assays; D002465:Cell Movement; D025461:Feedback, Physiological; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000378:metabolism*; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism*; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D059648:Kisspeptins / Q000378:metabolism*; D020935:MAP Kinase Signaling System; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D000074502:Receptors, Kisspeptin-1; D038744:Ribosomal Protein S6 Kinases, 90-kDa / Q000378:metabolism; D014327:Trophoblasts / Q000502:physiology*
chemical_list: C106628:KISS1 protein, human; C118688:KISS1R protein, human; D059648:Kisspeptins; D043562:Receptors, G-Protein-Coupled; D000074502:Receptors, Kisspeptin-1; D051416:Focal Adhesion Protein-Tyrosine Kinases; D000071679:Glycogen Synthase Kinase 3 beta; D038744:Ribosomal Protein S6 Kinases, 90-kDa; D038362:Glycogen Synthase Kinase 3